TYSLESS · BIO-NAT-2014-01
Public neurological clinical research study information. Check the current recruitment status in the live Wix study record.
A retrospective epidemiological study analysing clinical and radiological disease activity in patients with relapsing-remitting multiple sclerosis following natalizumab discontinuation in routine clinical practice.
Sponsor: BIOGEN
Phase: IV
Area: Neuroimmunology